Výsledky vyhledávání - Philip J. Stephens
- Zobrazuji výsledky 1 - 20 z 113
- Přejít na další stránku
-
1
Protein control of iron-sulfur cluster redox potentials. Autor Ralf Langen, Greg Jensen, U. Jacob, Philip J. Stephens, Arieh Warshel
Vydáno 1992Artigo -
2
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion Autor Lee A. Albacker, Jeremy Wu, Peter Smith, Markus Warmuth, Philip J. Stephens, Ping Zhu, Lihua Yu, Juliann Chmielecki
Vydáno 2017Artigo -
3
-
4
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Autor Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Vydáno 2017Artigo -
5
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies Autor Aaron M. Goodman, Shumei Kato, Philip R. Cohen, Amélie Boichard, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Vydáno 2017Artigo -
6
-
7
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors Autor Jennifer J. Wheler, Johnique T. Atkins, Filip Janků, Stacy L. Moulder, Philip J. Stephens, Roman Yelensky, Vicente Valero, Vincent A. Miller, Razelle Kurzrock, Funda Meric‐Bernstam
Vydáno 2016Artigo -
8
Identification of a Novel HIP1-ALK Fusion Variant in Non–Small-Cell Lung Cancer (NSCLC) and Discovery of ALK I1171 (I1171N/S) Mutations in Two ALK-Rearranged NSCLC Patients with Re... Autor Sai‐Hong Ignatius Ou, Samuel J. Klempner, Joel Greenbowe, Michele C. Azada, Alexa B. Schrock, Siraj M. Ali, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller
Vydáno 2014Artigo -
9
Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies Autor Jeffrey S. Ross, Siraj M. Ali, K. Wang, Gary A. Palmer, Roman Yelensky, Doron Lipson, V.A. Miller, Deborah A. Zajchowski, Laura K. Shawver, Philip J. Stephens
Vydáno 2013Artigo -
10
Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/G and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who pr... Autor Sai‐Hong Ignatius Ou, Jean Cui, Alexa B. Schrock, Michael E. Goldberg, Viola W. Zhu, Lee A. Albacker, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali
Vydáno 2017Artigo -
11
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions Autor Christine M. Lovly, Abha A. Gupta, Doron Lipson, Geoff Otto, Tina Brennan, Catherine T. Chung, Scott C. Borinstein, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Cheryl M. Coffin
Vydáno 2014Artigo -
12
Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib Autor Victor Wong, Dean C. Pavlick, Timothy J. Brennan, Roman Yelensky, John R. Crawford, Jeffrey S. Ross, Vincent A. Miller, Denise Malicki, Philip J. Stephens, Siraj M. Ali, Hyunah Ahn
Vydáno 2015Carta -
13
Oncogenic Alterations in <i>ERBB2/HER2</i> Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin Autor Juliann Chmielecki, Jeffrey S. Ross, Kai Wang, Garrett M. Frampton, Gary A. Palmer, Siraj M. Ali, Norma Alonzo Palma, Deborah Morosini, Vincent A. Miller, Roman Yelensky, Doron Lipson, Philip J. Stephens
Vydáno 2014Artigo -
14
Response of an <i>ERBB2</i>-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy Autor Siraj M. Ali, R. Katherine Alpaugh, Sean R. Downing, Philip J. Stephens, Jian Yu, Hong Wu, Jamie Buell, Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli
Vydáno 2014Artigo -
15
-
16
Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with <i>MYB</i>–<i>NFIB</i> Chimeric Fusion, <i>MYB</i> Expression... Autor Yoshitsugu Mitani, Pulivarthi H. Rao, P. Andrew Futreal, Dianna Roberts, Philip J. Stephens, Yi-Jue Zhao, Li Zhang, Mutsumi Mitani, Randal S. Weber, Scott M. Lippman, Carlos Caulı́n, Adel K. El‐Naggar
Vydáno 2011Artigo -
17
Identification and characterization of <i>RET</i> fusions in advanced colorectal cancer Autor Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Tara Elisabeth Seery, Eric M. Sanford, Sohail Balasubramanian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Vi K. Chiu
Vydáno 2015Artigo -
18
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer Autor Andrew Rankin, Samuel J. Klempner, Rachel Erlich, James Sun, Axel Grothey, Marwan Fakih, Thomas J. George, Jeeyun Lee, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Alexa B. Schrock
Vydáno 2016Artigo -
19
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway Autor Jennifer J. Wheler, Stacy Moulder, Aung Naing, Filip Janků, Sarina A. Piha‐Paul, Gerald S. Falchook, Ralph Zinner, Apostolia M. Tsimberidou, Siqing Fu, David S. Hong, Johnique T. Atkins, Roman Yelensky, Philip J. Stephens, Razelle Kurzrock
Vydáno 2014Artigo -
20
Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer Autor Nir Peled, Gary A. Palmer, Fred R. Hirsch, Murry W. Wynes, Maya Ilouze, Marileila Varella‐Garcia, Lior Soussan‐Gutman, Geoff Otto, Philip J. Stephens, Jeffrey S. Ross, Maureen Cronin, Doron Lipson, Vincent A. Miller
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer
Medicine
Cancer research
Genetics
Gene
Internal medicine
Oncology
Colorectal cancer
Mutation
KRAS
Pathology
Genome
Lung cancer
Targeted therapy
Breast cancer
Computational biology
Adenocarcinoma
CDKN2A
Exon
PI3K/AKT/mTOR pathway
PTEN
Bioinformatics
Copy-number variation
Fusion gene
Receptor
Apoptosis
Carcinoma
Computer science
Crizotinib